Covered recipient · General Payments record
MICHAEL DEAN KERBY
Eye and Vision Services Providers Optometrist
General Payments · PY2019–2024
$1,033.32
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $734.03 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CooperVision Inc. | $169.31 | 5 |
| ABBVIE INC. | $123.97 | 1 |
| Bausch & Lomb Americas Inc. | $117.29 | 1 |
| Tarsus Pharmaceuticals, Inc. | $117.07 | 1 |
| Astellas Pharma US Inc | $106.78 | 1 |
| Oyster Point Pharma, Inc. | $99.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $123.97 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104054182 | CMS |
| Astellas Pharma US Inc | $106.78 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139415475 | CMS |
| Bausch & Lomb Americas Inc. | $117.29 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140411079 | CMS |
| CooperVision Inc. | $20.99 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526607 | CMS |
| CooperVision Inc. | $86.86 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526609 | CMS |
| CooperVision Inc. | $19.49 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526663 | CMS |
| CooperVision Inc. | $25.43 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526661 | CMS |
| CooperVision Inc. | $16.54 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145526721 | CMS |
| Oyster Point Pharma, Inc. | $99.61 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147432573 | CMS |
| Tarsus Pharmaceuticals, Inc. | $117.07 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139107709 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.